SARS-CoV-2 memory CD4+ T cells were detected in almost all subjects after receiving the two-dose regimen of CoronaVac, as well as seen in a cohort of mostly non-hospitalized patients with COVID-19 (37). This evidence concerns the gene CD4 and COVID-19.